Advanced search
Publication Cover
Current Medical Research and Opinion Volume 21, 2005 - Issue 4
Submit an article Journal homepage
61
Views
18
CrossRef citations to date
0
Altmetric
Original Article

Service utilization and costs of olanzapine versus divalproex treatment for acute mania: results from a randomized, 47-week clinical trial

Baojin Zhu Lilly Research Laboratories, Indianapolis, IN, USACorrespondence[email protected]
,
Sandra L. Tunis Lilly Research Laboratories, Indianapolis, IN, USA
,
Zhongyun Zhao Lilly Research Laboratories, Indianapolis, IN, USA
,
Robert W. Baker Lilly Research Laboratories, Indianapolis, IN, USA
,
Maureen J. Lage HealthMetrics Outcomes Research, Groton Long Point, CT, USA
,
Lizheng Shi Lilly Research Laboratories, Indianapolis, IN, USA
&
Mauricio Tohen Lilly Research Laboratories, Indianapolis, IN, USA; Harvard Medical School, Department of Psychiatry, McLean Hospital, Belmont, MA, USA
 show all
Pages 555-564 | Accepted 16 Feb 2005, Published online: 17 Apr 2005

Citations (18)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Baojin Zhu, Pandurang M Kulkarni, Michael D. Stensland & Haya Ascher-Svanum. (2007) Medication patterns and costs associated with olanzapine and other atypical antipsychotics in the treatment of bipolar disorder. Current Medical Research and Opinion 23:11, pages 2805-2814.
Read now
Glen T. Schumock, Surrey M. Walton, Shiraz R. Gupta & Joyce A. Cramer. (2007) Cost analysis of divalproex sodium extended-release compared to valproic acid in the treatment of bipolar disorder. Current Medical Research and Opinion 23:8, pages 1997-2004.
Read now
J. Jaime Caro, Krista F. Huybrechts, James G. Xenakis, Judith A. O’Brien, Krithika Rajagopalan & Karen Lee. (2006) Budgetary impact of treating acute bipolar mania in hospitalized patients with quetiapine: an economic analysis of clinical trials. Current Medical Research and Opinion 22:11, pages 2233-2242.
Read now

Articles from other publishers (15)

Georgios Schoretsanitis & Michael Paulzen. 2022. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy 1469 1491 .
Georgios Schoretsanitis & Michael Paulzen. 2019. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy 1 24 .
Konstantinos N. Fountoulakis, Lakshmi Yatham, Heinz Grunze, Eduard Vieta, Allan Young, Pierre Blier, Siegfried Kasper & Hans Jurgen Moeller. (2016) The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise Algorithm. International Journal of Neuropsychopharmacology, pages pyw100.
Crossref
Kostas N. FountoulakisKostas N. Fountoulakis. 2015. Bipolar Disorder. Bipolar Disorder 461 625 .
Konstantinos N. Fountoulakis, Siegfried Kasper, Ole Andreassen, Pierre Blier, Ahmed Okasha, Emanuel Severus, Marcio Versiani, Rajiv Tandon, Hans-Jürgen Möller & Eduard Vieta. (2012) Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry. European Archives of Psychiatry and Clinical Neuroscience 262:S1, pages 1-48.
Crossref
R. Sabes‐Figuera, D. Razzouk & Paul E. McCrone. 2010. Bipolar Disorder. Bipolar Disorder 90 95 .
Ying Qiu, Alex Z. Fu, Gordon G. Liu & Dale B. Christensen. (2010) Healthcare Costs of Atypical Antipsychotic Use for Patients with Bipolar Disorder in a Medicaid Programme. Applied Health Economics and Health Policy 8:3, pages 167-177.
Crossref
Kathleen Lang, Martin D. Marciniak, Douglas Faries, Michael Stokes, Don Buesching, Craig Earle, Joseph Treat, Steve Babineaux, Nathalie Morissette & David Thompson. (2009) Costs of First-Line Doublet Chemotherapy and Lifetime Medical Care in Advanced Non–small-Cell Lung Cancer in the United States. Value in Health 12:4, pages 481-488.
Crossref
Baojin Zhu, Haya Ascher-Svanum, Douglas E Faries, Christoph U Correll & John M Kane. (2008) Cost of antipsychotic polypharmacy in the treatment of schizophrenia. BMC Psychiatry 8:1.
Crossref
Konstantinos N Fountoulakis, Eduard Vieta, Melina Siamouli, Marc Valenti, Stamatia Magiria, Timucin Oral, David Fresno, Panteleimon Giannakopoulos & George S Kaprinis. (2007) Treatment of bipolar disorder: a complex treatment for a multi-faceted disorder. Annals of General Psychiatry 6:1.
Crossref
Haya Ascher-Svanum, Baojin Zhu, Douglas Faries, Ron Landbloom, Marvin Swartz & Jeff Swanson. (2006) Time to discontinuation of atypical versus typical antipsychotics in the naturalistic treatment of schizophrenia. BMC Psychiatry 6:1.
Crossref
Richard H. Weisler, Andrew J. Cutler, James C. Ballenger, Robert M. Post & Terence A. Ketter. (2014) The Use of Antiepileptic Drugs in Bipolar Disorders: A Review Based on Evidence From Controlled Trials . CNS Spectrums 11:10, pages 788-799.
Crossref
F. Limosin. (2006) Épidémiologie des prescriptions médicamenteuses dans les troubles bipolaires. L'Encéphale 32:3, pages 41-44.
Crossref
Rachael L Fleurence, Julia M Dixon & Dennis A Revicki. (2006) Economics of Atypical Antipsychotics in Bipolar Disorder. CNS Drugs 20:7, pages 591-599.
Crossref
Armand Hausmann, Robert Strauss, Ulrike Weiss & Andreas Conca. (2005) Sind Antipsychotika der zweiten und dritten Generation auch Phasenprophylaktika?Are second and third generation antipsychotics moodstabilizers? A systematical analysis of the literature. Psychiatrie und Psychotherapie 1:2, pages 75-90.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.